[
  {
    "ts": null,
    "headline": "Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne",
    "summary": "Gemini Bioproducts, LLC (\"GeminiBio\"), a leading supplier of cell culture reagents and process liquids, and a portfolio company of BelHealth Investment Partners, LLC (\"BelHealth\"), a Florida-based healthcare private equity firm, today announced the acquisition of selected fetal bovine serum (FBS) product rights and inventory from Bio-Techne (NASDAQ: TECH).",
    "url": "https://finnhub.io/api/news?id=a4104bac78c676837f457a027507409c44bdc4f999b8f048a94c7f63b62c740b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732543320,
      "headline": "Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne",
      "id": 131647349,
      "image": "https://media.zenfs.com/en/prnewswire.com/29d3fcb84687ad905ef0299ddab9ea81",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Gemini Bioproducts, LLC (\"GeminiBio\"), a leading supplier of cell culture reagents and process liquids, and a portfolio company of BelHealth Investment Partners, LLC (\"BelHealth\"), a Florida-based healthcare private equity firm, today announced the acquisition of selected fetal bovine serum (FBS) product rights and inventory from Bio-Techne (NASDAQ: TECH).",
      "url": "https://finnhub.io/api/news?id=a4104bac78c676837f457a027507409c44bdc4f999b8f048a94c7f63b62c740b"
    }
  }
]